TRIAL DETAIL
SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue Sarcomas
Drug: |
||||
|---|---|---|---|---|
Trial Name: |
SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue Sarcomas |
|||
NCT#: |
||||
Conditions: |
Gastrointestinal Stromal Tumor; Sarcoma |
|||
Status: |
Completed |
|||
Phase: |
2 |
Start Date 10/01/2000 |
Age of Trial (yrs) 24.2 |
|
Treatment Phase: |
All |
|||
Drug Category: |
VEGFR inhibitor (TKI) |
|||
Strategy: |
Block tumor blood vessel growth |
|||
Trial Type: |
GIST not specified. GIST patients known to be enrolled. |
|||
Other Protocol IDs: |
CDR000006789, DFCI-00002, NCI-330 |
|||
Sponsor: |
Dana-Farber,
NCI |
|||
Patient Contact: |
||||
Contact email: |
||||
Contact Phone: |
||||
Randomized: |
||||
IV or Oral: |
Intravenous |
|||
Trial Notes: |
||||
Trial Links |
Trial Results |
Drug Information |
| Semaxanib in Wikipedia |
Trial Sites
Name |
Address |
City |
State |
Zip |
Country |
450 Brookline Ave |
Boston |
MA |
02215-5450 |
USA |